2021
DOI: 10.1016/j.jjcc.2020.12.013
|View full text |Cite
|
Sign up to set email alerts
|

Uric acid and cardiovascular disease: A clinical review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
139
0
6

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 180 publications
(173 citation statements)
references
References 73 publications
3
139
0
6
Order By: Relevance
“…Uric acid is the end-product of purine metabolism in humans, which play crucial roles in developing cardiovascular diseases including CHD [ 47 ]. Hyperuricemia is a potential risk factor for CHD [ 48 , 49 ].…”
Section: Discussionmentioning
confidence: 99%
“…Uric acid is the end-product of purine metabolism in humans, which play crucial roles in developing cardiovascular diseases including CHD [ 47 ]. Hyperuricemia is a potential risk factor for CHD [ 48 , 49 ].…”
Section: Discussionmentioning
confidence: 99%
“…We and other groups have previously shown the SUA level as a marker or predictor of systemic endothelial dysfunction in patients with ACS and INOCA [ 6 , 7 , 8 ], and the present study supported the concept in the entire spectrum of IHD. While numerous epidemiological studies have reported the association of the SUA level with cardiovascular disease, including IHD [ 5 ], a therapeutic intervention targeting SUA in IHD has not been fully investigated. Noman et al previously demonstrated that in CCS patients with angiographically confirmed obstructive CAD, allopurinol (600 mg/day) significantly improved exercise capacity in a randomized, placebo-controlled, cross-over setting [ 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…Uric acid, the end-product of purine metabolism in humans, is associated with inflammation, oxidative stress, and endothelial dysfunction, contributing to the development of atherosclerotic diseases including IHD [ 5 ]. Previous studies have indicated that urate lowering therapy had an effect on blood pressure and endothelial function [ 5 ], and we and others have reported that the serum uric acid (SUA) level was a marker or predictor of systemic endothelial dysfunction in patients with ACS and INOCA [ 6 , 7 , 8 ]. However, whether the SUA level is associated with impaired endothelial function in patients with a broad spectrum of IHD is unclear.…”
Section: Introductionmentioning
confidence: 99%
“…In humans, the final oxidative product of purine catabolism is known as Serum uric acid. Various studies indicate a strong association between atherosclerotic disease and serum uric acid [7][8][9][10][11][12]. Feng et al (2018) [13] studied 564 people in China and suggested that serum uric acid levels are associated with the development and progression of atherosclerotic vascular changes.…”
Section: Introductionmentioning
confidence: 99%